This stimulating book consists of a collection of 27 interviews with some of the key researchers in the field of psychopharmacology, including senior clinicians, basic scientists and drug developers within the pharmaceutical industry. Theses important interviews will require the histories of the antidepressants and the antipsychotics to be rewritten. They provide a unique perspective on interactions between cultural, commercial and regulatory frameworks...